lobbying_activities: 2191422
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2191422 | d0fb72fe-fe23-4cbc-8b7b-82edb74c4520 | Q3 | MEHLMAN CONSULTING, INC. | 284950 | ASCENSION HEALTH ALLIANCE | 2018 | third_quarter | PHA | Prescription drug pricing. S. 974 - CREATES Act of 2017. 340B Drug Pricing Program. H.R. 6 - SUPPORT for Patients and Communities Act. S. 3120 - HEAL Act of 2018. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2018-10-18T13:18:26.677000-04:00 |